• Home
  • Search
  • Multiple sclerosis, fertility, pregnancy, and assisted reproductive technology: Current knowledge.
  • Cite Icon1
  • https://doi.org/10.1016/j.jogoh.2025.103061Copy DOI Icon

Multiple sclerosis, fertility, pregnancy, and assisted reproductive technology: Current knowledge.

Show More
  • Abstract
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Multiple sclerosis, fertility, pregnancy, and assisted reproductive technology: Current knowledge.

Similar Papers
  • Research Article

Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over

  • Jan 01, 2025
  • Universität Zürich, ZORA
  • Mina Stanikić +10
  • Research Article
  • Citations1

Clinical characteristics of multiple sclerosis in older adults in a Finnish Tertiary Centre.

  • Nov 01, 2025
  • Clinical neurology and neurosurgery
  • Iiro Korhonen +3
  • Discussion
  • Citations23

Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19+B-cell repopulation

  • Sep 27, 2021
  • Multiple Sclerosis and Related Disorders
  • Nitin Kumar Sahi +5
  • Research Article

Factors affecting prognosis in patients with relapsing remitting multiple sclerosis

  • Jun 25, 2023
  • Zagazig University Medical Journal
  • Bothina Ramadan +3
  • Research Article
  • Citations29

Decreased risk of cancer in multiple sclerosis patients and analysis of the effect of disease modifying therapies on cancer risk

  • Sep 09, 2016
  • Journal of the Neurological Sciences
  • Deeya Gaindh +6
  • Research Article
  • Citations36

Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience.

  • Apr 30, 2021
  • Neurologia i Neurochirurgia Polska
  • Agata Czarnowska +60
  • Research Article
  • Citations61

An overview of pregnancy-related issues in patients with multiple sclerosis.

  • Sep 16, 2015
  • European Journal of Neurology
  • C Pozzilli +1
  • Research Article
  • Citations1

Should Spinal MRI Be Routinely Performed in Patients With Clinically Isolated Optic Neuritis?

  • Dec 01, 2018
  • Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
  • Ethan Meltzer +4
  • Research Article
  • Citations3

Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic.

  • Oct 01, 2023
  • Multiple sclerosis and related disorders
  • Patricia K Coyle +7
  • Research Article
  • Citations1

Implementation of a pharmacist‐managed population health monitoring tool for disease modifying therapies in treatment of patients with multiple sclerosis in a veterans affairs medical center

  • Sep 29, 2021
  • JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  • Alison W Martin +2
  • PDF
  • Research Article
  • Citations24

What Do Healthcare Providers Advise Women with Multiple Sclerosis Regarding Pregnancy?

  • Jan 01, 2014
  • Multiple Sclerosis International
  • Annette Wundes +2
  • Research Article
  • Citations21

Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS.

  • Apr 23, 2018
  • Neurology
  • John R Corboy +2
  • Research Article
  • Citations6

The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation

  • Nov 28, 2020
  • Multiple Sclerosis and Related Disorders
  • Francisco Javier Carod-Artal
  • Research Article
  • Citations12

Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based study

  • Jul 10, 2021
  • Revue Neurologique
  • S Leblanc +4
  • Research Article
  • Citations3

Neurofilament heavy chain and chitinase 3-like 1 as markers for monitoring therapeutic response in multiple sclerosis

  • Oct 02, 2024
  • Multiple Sclerosis and Related Disorders
  • P Kusnierova +9
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.